4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-17-005347
Options or other derivatives
- Chief Medical Officer acquired 16,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BARTLETT ROBERT HAWES Chief Medical Officer | 2017-01-30 | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | D | ||
Loading xslF345X03/v458131_4.xml…